BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1854962)

  • 1. [The characteristics of the cardioprotective action of fructose-1,6-diphosphate].
    Sernov LN; Rozonov IuB; Sokolova OA; Shal'neva TV; Snegireva GV; Gatsura VV
    Biull Eksp Biol Med; 1991 Feb; 111(2):172-3. PubMed ID: 1854962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of fructose-1,6-diphosphate, cytochrome c and their combination on the size of the necrotic area in transient myocardial ischemia].
    Imatdieva RM; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(1):32-4. PubMed ID: 9162279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antiacidotic and cardioprotective effects of fructose-1,6-diphosphate and dehydroascorbic acid].
    Sernov LN; Sokolova OA; Gatsura VV
    Farmakol Toksikol; 1991; 54(4):24-6. PubMed ID: 1786815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents].
    Sernov LN; Rozonov IuB; Gatsura VV
    Eksp Klin Farmakol; 1992; 55(4):13-5. PubMed ID: 1458176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of fructose-1,6-diphosphate and dexamethasone on ischemia/reperfusion injury after hemorrhagic shock in rabbits].
    Chen YQ; Jin XJ; Tang RH; Huang WB; Tao QS; Wang BA
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jan; 16(1):29-32. PubMed ID: 14706200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.
    Cohen JE; Atluri P; Taylor MD; Grand TJ; Liao GP; Panlilio CM; Suarez EE; Zentko SE; Hsu VM; Berry MF; Smith MJ; Gardner TJ; Sweeney HL; Woo YJ
    Heart Lung Circ; 2006 Apr; 15(2):119-23. PubMed ID: 16469539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of hypothermic heart preservation with fructose 1, 6-diphosphate.
    Niu W; Zhang F; Ehringer W; Tseng M; Gray L; Chien S
    J Surg Res; 1999 Jul; 85(1):120-9. PubMed ID: 10383848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cardioprotective action of preparations of biotechnological cytochrome c in acute myocardial ischemia].
    Gatsura VV; Sernov LN; Davidov ER
    Eksp Klin Farmakol; 1998; 61(2):27-9. PubMed ID: 9621169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of fructose-1,6-diphosphate on myocardial purin and pyrimidin metabolism during coronary artery bypass grafting surgery].
    Gál J; Riedel BJ; Róth E; Bogár L; Tekeres M; Royston D
    Orv Hetil; 2000 Sep; 141(37):2021-5. PubMed ID: 11037610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rat.
    Didlake R; Kirchner KA; Lewin J; Bower JD; Markov A
    Circ Shock; 1985; 16(2):205-12. PubMed ID: 4053295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of fructose 1,6 diphosphate for salvage of ischemic gracilis flaps in rats.
    Sud V; Lindley SG; McDaniel O; Freeland AE; Zhang F; Dorsett-Martin W; Bigler SA; Lineaweaver W
    J Reconstr Microsurg; 2005 Apr; 21(3):191-6. PubMed ID: 15880299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effect of fructose-1,6-diphosphate against ultrastructural damage in the hippocampus of rats with repeated febrile seizures].
    Zhou JP; Wang F; Yang L; Huang SP; Li RL
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):199-202. PubMed ID: 18433547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection using fructose-1,6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial.
    Riedel BJ; Gal J; Ellis G; Marangos PJ; Fox AW; Royston D
    Anesth Analg; 2004 Jan; 98(1):20-29. PubMed ID: 14693576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of coronary artery occlusion and reperfusion for the discovery of novel antiischemic and antiinflammatory drugs for the heart.
    Wayman NS; McDonald MC; Chatterjee PK; Thiemermann C
    Methods Mol Biol; 2003; 225():199-208. PubMed ID: 12769489
    [No Abstract]   [Full Text] [Related]  

  • 15. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
    Brown EJ; Erburu L; Kloner RA
    J Med; 1987; 18(1):43-53. PubMed ID: 3474341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the antianginal action of pharmacological substances by the change in the initiation threshold for myocardial ischemia in conscious rabbits].
    Rozonov IuB; Morozova TV
    Biull Eksp Biol Med; 1984 Oct; 98(10):460-2. PubMed ID: 6437458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship of antioxidant and anti-ischemic effects of various energy-yielding compounds].
    Sergeev PV; Snegireva GV; Gukasov VM; Gatsura VV
    Biull Eksp Biol Med; 1991 Oct; 112(10):381-2. PubMed ID: 1666519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease].
    Badalian GO; Episkoposian NG; Amatuni GV
    Ter Arkh; 1987; 59(7):92-5. PubMed ID: 3672368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of post-arrest cardiac performance: effect of fructose-1,6-diphosphate in the isolated rabbit heart.
    Merli M; Bergui G; Cattani C; Berti F; Marchetti M
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):175-82. PubMed ID: 2799003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of fructose-1,6-diphosphate and phosphoenolpyruvate on the course of early occlusion and reperfusion arrhythmias in rats].
    Balashov VP; Kostin IaV; Sedova DG; Sernov LN; Gatsura VV
    Biull Eksp Biol Med; 1993 Jun; 115(6):629-30. PubMed ID: 8374147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.